Yr Athro Rosemary Barnes

2024

• Coyle, V. et al. 2024. Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial. Clinical Microbiology and Infection 30(1), pp. 92-99. (10.1016/j.cmi.2023.07.021)

2023

• Cruciani, M. et al. 2023. An overview of systematic reviews of polymerase chain reaction (PCR) for the diagnosis of invasive aspergillosis in immunocompromised people: a report of the fungal PCR initiative (FPCRI)—an Isham Working Group. Journal of Fungi 9(10), article number: 967. (10.3390/jof9100967)
• Maertens, J. et al. 2023. Empiric vs preemptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the european organization for research and treatment of cancer. Clinical Infectious Diseases 76(4), pp. 674-682. (10.1093/cid/ciac623)

2021

• Griffiths, J. S. et al. 2021. A novel strategy to identify haematology patients at high risk of developing Aspergillosis. Frontiers in Immunology 12, article number: 780160. (10.3389/fimmu.2021.780160)
• White, P. L., Posso, R., Parr, C., Price, J. S., Finkelman, M. and Barnes, R. A. 2021. The presence of (1→3)-β-D-glucan as prognostic marker in patients after major abdominal surgery. Clinical Infectious Diseases 73(7), pp. e1415-e1422., article number: ciaa1370. (10.1093/cid/ciaa1370)
• Rossignol, T. et al. 2021. Ethylzingerone, a novel compound with antifungal activity. Antimicrobial Agents and Chemotherapy 65(4), article number: e02711-20. (10.1128/AAC.02711-20)
• Cruciani, M. et al. 2021. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. Journal of Antimicrobial Chemotherapy 76(3), pp. 635-638. (10.1093/jac/dkaa498)
• Rocchi, S. et al. 2021. Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: a study by the fungal PCR Initiative and the Modimucor study group. Medical Mycology 59(2), pp. 126-138. (10.1093/mmy/myaa036)

2019

• Cruciani, M. et al. 2019. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised patients. Cochrane Database of Systematic Reviews(9), pp. -., article number: CD009551. (10.1002/14651858.CD009551.pub4)

2018

• Ullmann, A. J. et al. 2018. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection 24(Supple), pp. e1-e38. (10.1016/j.cmi.2018.01.002)
• Barnes, R. A., White, P. L., Morton, C. O., Rogers, T. R., Cruciani, M., Loeffler, J. and Donnelly, J. P. 2018. Diagnosis of aspergillosis by PCR: clinical considerations and technical tips. Medical Mycology 56(S1), pp. S60-S72., article number: myx091. (10.1093/mmy/myx091)
• White, P. L., Parr, C. and Barnes, R. A. 2018. Predicting invasive aspergillosis in haematology patients by combining clinical and genetic risk factors with early diagnostic biomarkers. Journal of Clinical Microbiology 56(1), article number: e01122-17. (10.1128/JCM.01122-17)

2017

• White, P. L., Price, J. S., Posso, R. B. and Barnes, R. A. 2017. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to 2 assist in the diagnosis of Pneumocystis pneumonia. Medical Mycology 55(8), pp. 843-850. (10.1093/mmy/myx004)
• Morton, C. O. et al. 2017. Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?. Medical Mycology 55(4), pp. 402-413. (10.1093/mmy/myw093)
• White, P. L., Posso, R. B., Barnes, R. A. and Warnock, D. W. 2017. Analytical and clinical evaluation of the PathoNostics AsperGenius Assay for detection of invasive aspergillosis and resistance to azole antifungal drugs directly from plasma samples. Journal of Clinical Microbiology 55(8), pp. 2356-2366. (10.1128/JCM.00411-17)
• Wattal, C. et al. 2017. Issues in antifungal stewardship: an opportunity that should not be lost. Journal of Antimicrobial Chemotherapy 72(4), pp. 969-974. (10.1093/jac/dkw506)
• White, P. L., Backx, M. and Barnes, R. 2017. Diagnosis and management of Pneumocystis jirovecii infection. Expert Review of Anti-infective Therapy 15(5), pp. 435-447. (10.1080/14787210.2017.1305887)
• Sands, K. M. et al. 2017. Respiratory pathogen colonisation of dental plaque, the lower airways and endotracheal tube biofilms during mechanical ventilation. Journal of Critical Care 37, pp. 30-37. (10.1016/j.jcrc.2016.07.019)
• White, P. L. and Barnes, R. A. 2017. Isolation of nucleic acids for fungal diagnosis. In: Lion, T. ed. Human Fungal Pathogen Identification: Methods and Protocols., Vol. 1508. Methods in Molecular Biology Springer, pp. 223-247., (10.1007/978-1-4939-6515-1_12)

2016

• Agrawal, S., Barnes, R., Brüggemann, R. J., Rautemaa-Richardson, R. and Warris, A. 2016. The role of the multidisciplinary team in antifungal stewardship. Journal of Antimicrobial Chemotherapy 71(Supp 2), pp. ii37-ii42. (10.1093/jac/dkw395)
• Shahin, J. et al. 2016. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units. BMC Infectious Diseases 16(1), article number: 480. (10.1186/s12879-016-1803-9)
• Springer, J. et al. 2016. Comparison of performance characteristics of Aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations. Journal of Clinical Microbiology 54(3), pp. 705-711. (10.1128/JCM.02814-15)
• White, P. L. et al. 2016. Comparison of nonculture blood-based tests for diagnosing invasive Aspergillosis in an animal model. Journal of Clinical Microbiology 54(4), pp. 960-966. (10.1128/JCM.03233-15)

2015

• White, P. L. et al. 2015. Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing. Clinical Infectious Diseases 61(8), pp. 1293-1303. (10.1093/cid/civ507)
• Wise, M. et al. 2015. Guidelines on the management and admission to intensive care of critically ill adult patients with haematological malignancy in the UK. British Journal of Haematology 171(2), pp. 179-188. (10.1111/bjh.13594)
• Loeffler, J. et al. 2015. Analytical comparison of in vitro-spiked human serum and plasma for PCR-based detection of Aspergillus fumigatus DNA: a study by the European Aspergillus PCR Initiative. Journal of Clinical Microbiology 53(9), pp. 2838-2845. (10.1128/JCM.00906-15)
• White, P. L. et al. 2015. Clinical performance of Aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative. Journal of Clinical Microbiology 53(9), pp. 2832-2837. (10.1128/JCM.00905-15)
• White, P. L., Posso, R. and Barnes, R. A. 2015. An analytical and clinical evaluation of the PathoNostics AsperGenius Assay for detection of Invasive Aspergillosis and resistance to azole antifungal drugs when testing serum samples.. Journal of Clinical Microbiology 53(7), pp. 2115-2121. (10.1128/JCM.00667-15)
• Barnes, R. A. et al. 2015. Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients. Clinical Therapeutics 37(6), pp. 1317-1318. (10.1016/j.clinthera.2015.03.021)
• Schelenz, S., Barnes, R. A., Barton, R. C., Cleverley, J. R., Lucas, S. B., Kibbler, C. C. and Denning, D. W. 2015. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infectious Diseases 15(4), pp. 461-474. (10.1016/S1473-3099(15)70006-X)

2014

• Barnes, R. A., Gow, N. A. R., Denning, D. W., May, R. C. and Haynes, K. 2014. Antifungal resistance: more research needed. The Lancet 384(9952), pp. 1427-1427. (10.1016/S0140-6736(14)61861-4)
• White, P. L. et al. 2014. Evaluation of a commercially developed semiautomated PCR-surface-enhanced Raman scattering assay for diagnosis of invasive fungal disease. Journal of Clinical Microbiology 52(10), pp. 3536-3543. (10.1128/JCM.01135-14)
• Barnes, R., White, P. L. and Doern, G. V. 2014. Not Over Yet: Fungal Infections following Methyl Prednisolone Injections Smoulder On. Journal of Clinical Microbiology 52(9), pp. 3506-3507. (10.1128/JCM.01634-14)
• Kimpton, G., White, P. L. and Barnes, R. A. 2014. The effect of sample storage on the performance and reproducibility of the galactomannan EIA test. Medical Mycology 52(6), pp. 618-626. (10.1093/mmy/myu014)
• Backx, M., White, P. L. and Barnes, R. A. 2014. New fungal diagnostics. British Journal of Hospital Medicine 75(5), pp. 271-276. (10.12968/hmed.2014.75.5.271)
• Ashbee, H. R., Barnes, R. A., Johnson, E. M., Richardson, M. D., Gorton, R. and Hope, W. W. 2014. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. Journal of Antimicrobial Chemotherapy 69(5), pp. 1162-1176. (10.1093/jac/dkt508)
• Drgona, L., Khachatryan, A., Stephens, J., Charbonneau, C., Kantecki, M., Haider, S. and Barnes, R. A. 2014. Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. European Journal of Clinical Microbiology & Infectious Diseases 33(1), pp. 7-21. (10.1007/s10096-013-1944-3)
• Perry, M. D., White, P. L. and Barnes, R. 2014. Comparison of four automated nucleic acid extraction platforms for the recovery of DNA from Aspergillus fumigatus. Journal of Medical Microbiology 63, pp. 1160-1166. (10.1099/jmm.0.076315-0)

2013

• Barnes, R. A. 2013. Infection in cancer and transplantation [Review]. Medicine 41(11), pp. 624-627. (10.1016/j.mpmed.2013.08.009)
• Barnes, R. A. 2013. Directed therapy for fungal infections: focus on aspergillosis. Journal of Antimicrobial Chemotherapy 68(11), pp. 2431-2434. (10.1093/jac/dkt227)
• Barnes, R. A., Stocking, K., Bowden, S., Poynton, M. H. and White, P. L. 2013. Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway. Journal of Infection 67(3), pp. 206-214. (10.1016/j.jinf.2013.04.020)
• Lyon, G. M. et al. 2013. Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing Aspergillosis. Journal of Clinical Microbiology 51(7), pp. 2403-2405. (10.1128/JCM.00744-13)
• White, P., Parr, C., Thornton, C. and Barnes, R. 2013. Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. Journal of Clinical Microbiology 51(5), pp. 1510-1516. (10.1128/JCM.03189-12)
• White, P., Jones, T., Whittle, K., Watkins, J. and Barnes, R. A. 2013. Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samples. Clinical and Vaccine Immunology 20(4), pp. 636-638. (10.1128/CVI.00730-12)

2012

• Agrawal, S. et al. 2012. A practical critique of antifungal treatment guidelines for haemato-oncologists. Critical Reviews in Microbiology 38(3), pp. 203-216. (10.3109/1040841X.2011.645521)
• Barnes, R. A. 2012. Pneumonia and ACE inhibitors - and cough [Editorial]. British Medical Journal 345, article number: e4566. (10.1136/bmj.e4566)
• Cruciani, M., Mengoli, C., Donnelly, P., Loeffler, J. and Barnes, R. A. 2012. Polymerase chain reaction for diagnosing invasive aspergillosis: systematic review and meta-analysis [Abstract]. Mycoses -Berlin- 55(s4), pp. 50. (10.1111/j.1439-0507.2012.02204.x)
• Stirling, E. J. et al. 2012. A novel clinical diagnostic assay for the identification of multiple human fungal pathogens in a single sample [Abstract]. Mycoses -Berlin- 55(s4), pp. 78. (10.1111/j.1439-0507.2012.02205.x)
• Loeffler, J., Barnes, R. A. and Donnelly, J. P. 2012. Standardization of Aspergillus PCR diagnosis [Letter]. Bone Marrow Transplantation 47(2), pp. 299-300. (10.1038/bmt.2011.58)

2011

• White, P. L., Perry, M. D., Moody, A., Follett, S. A., Morgan, G. and Barnes, R. A. 2011. Evaluation of analytical and preliminary clinical performance of myconostica mycAssay aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. Journal of Clinical Microbiology 49(6), pp. 2169-2174. (10.1128/JCM.00101-11)
• Barnes, R. A. 2011. M06a How to manage the EORTC/MSG definitions in daily practice [Abstract]. Mycoses 54(s2), pp. 47-48. (10.1111/j.1439-0507.2011.02091.x)
• Barnes, R. A. 2011. Fungal infections. In: Rello, J., Valles, J. and Kollef, M. H. eds. Critical Care Infectious Diseases Textbook. Norwell, MA: Kluwer Academic Publishers, pp. 57-75.
• White, P. L., Perry, M. D. and Barnes, R. 2011. Candida. In: Liu, D. ed. Molecular detection of human fungal pathogens. Boca Raton, Fl: CRC Press
• Moore, C. et al. 2011. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. International Journal of Infectious Diseases 203(1), pp. 18-24. (10.1093/infdis/jiq007)
• White, P. L. et al. 2011. Evaluation of aspergillus PCR protocols for testing serum specimens. Journal of Clinical Microbiology 49(11), pp. 3842-3848. (10.1128/JCM.05316-11)

2010

• White, P. L. et al. 2010. Aspergillus PCR: One step closer to standardization. Journal of Clinical Microbiology 48(4), pp. 1231-1240. (10.1128/JCM.01767-09)
• Gaur, S., Marrin, C. A. and Barnes, R. A. 2010. Disseminated protothecosis following traumatic Hickman line removal in a patient with leukaemia. Medical Mycology 48(2), pp. 410-412. (10.3109/13693780903188698)
• Barnes, R. A. and White, P. L. 2010. Polymerase chain reaction (PCR) - based tests. In: Pasqualotto, A. C. ed. Aspergillosis: from diagnosis to prevention. London: Springer, pp. 135-158., (10.1007/978-90-481-2408-4_9)
• White, P. L., Hibbitts, S. J., Perry, M. D. and Barnes, R. A. 2010. Candida. In: Liu, D. ed. Molecular Detection of Foodborne Pathogens. Boca Raton, FL: CRC Press, pp. 549-564.
• White, P. L. et al. 2010. Critical stages of extracting DNA from aspergillus fumigatus in whole-blood specimens. Journal of Clinical Microbiology 48(10), pp. 3753-3755. (10.1128/JCM.01466-10)

2009

• Saayman, A. G., Findlay, G. P., Barnes, R. A. and Wise, M. P. 2009. Bacteraemia following single-stage percutaneous dilatational tracheostomy. Intensive Care Medicine 35(11), pp. 1970-1973. (10.1007/s00134-009-1586-1)
• White, P. L., Perry, M. D. and Barnes, R. A. 2009. An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiology Letters 296(1), pp. 1-10. (10.1111/j.1574-6968.2009.01575.x)
• Mengoli, C., Cruciani, M., Barnes, R. A., Loeffler, J. and Donnelly, J. P. 2009. Use of PCR for diagnosis of invasive aspergillosis: Systematic review and meta-analysis. The Lancet Infectious Diseases 9(2), pp. 89-96. (10.1016/S1473-3099(09)70019-2)
• White, P. L. and Barnes, R. A. 2009. Aspergillus PCR. In: Latge, J. and Steinbach, W. J. eds. Aspergillus Fumigatus and Aspergillosis. Washington: American Society for Microbiology, pp. 373-388.
• Lambourne, J. et al. 2009. Association of mannose binding Lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clinical Infectious Diseases 49(10), pp. 1486-1491. (10.1086/644619)
• Schelenz, S., Barnes, R. A., Kibbler, C. C., Jones, B. L. and Denning, D. W. 2009. Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit. Journal of Infection 58(2), pp. 145-153. (10.1016/j.jinf.2008.12.006)

2008

• Pfaller, M. A. et al. 2008. Geographic and temporal trends in isolation and antifungal susceptibility of candida parapsilosis: a global assessment from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005. Journal of Clinical Microbiology 46(3), pp. 842-849. (10.1128/JCM.02122-07)
• Barnes, R. A., White, P. L., Bygrave, C. A., Evans, N., Healy, B. J. and Kell, W. J. 2008. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. Journal of Clinical Pathology 62(1), pp. 64-69. (10.1136/jcp.2008.058354)

2007

• Shetty, A., Barnes, R. A., Lazda, E. J., Doherty, C. and Maxwell, N. 2007. Cytomegalovirus: A cause of colonic stricture in a premature infant. Journal of Infection 54(1), pp. e37-e39. (10.1016/j.jinf.2006.03.027)
• Barnes, R. A. and Sinha, J. 2007. Fungal infections. In: Rello, J. et al. eds. Infectious Diseases in Critical Care (2nd ed.). Berlin: Springer, pp. 65-77., (10.1007/978-3-540-34406-3_7)

2006

• Healy, B., Barnes, R. A., Hope-Gill, B., Ramanujam, S. and Baboolal, K. 2006. Man and woman flu. British Journal of Hospital Medicine 67(12), pp. 668-669.
• White, P. L. et al. 2006. A Consensus on Fungal Polymerase Chain Reaction Diagnosis?: A United Kingdom-Ireland Evaluation of Polymerase Chain Reaction Methods for Detection of Systemic Fungal Infections. The Journal of Molecular Diagnostics 8(3), pp. 376-384. (10.2353/jmoldx.2006.050120)
• White, P. L., Linton, C. J., Perry, M. D., Johnson, E. M. and Barnes, R. A. 2006. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clinical Infectious Diseases 42(4), pp. 479-486. (10.1086/499949)
• Shetty, A., Barnes, R. A., Adappa, R. and Doherty, C. 2006. Quality control of expressed breast milk [Letter]. Journal of Hospital Infection 62(2), pp. 253-254. (10.1016/j.jhin.2005.06.016)
• Ullmann, A. J. et al. 2006. Prospective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries. Clinical Infectious Diseases 43(4), pp. e29-e38. (10.1086/505969)

2005

• Pfaller, M. A. et al. 2005. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-Year Analysis of Susceptibilities of Candida and Other Yeast Species to Fluconazole and Voriconazole by Standardized Disk Diffusion Testing. Journal of Clinical Microbiology 43(12), pp. 5848-5859. (10.1128/JCM.43.12.5848-5859.2005)
• Shetty, A., Barnes, R. A., Healy, B. and Groves, P. 2005. A case of sepsis caused by Acidovorax. Journal of Infection 51(3), pp. e171-e172. (10.1016/j.jinf.2004.12.014)
• White, P. L., Archer, A. E. and Barnes, R. A. 2005. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. Journal of Clinical Microbiology 43(5), pp. 2181-2187. (10.1128/JCM.43.5.2181-2187.2005)
• Barnes, R. A. and Vale, L. 2005. 'Spiking' as a rapid method for differentiation of Candida albicans from other yeast species. Journal of Hospital Infection 60(1), pp. 78-80. (10.1016/j.jhin.2004.09.040)
• Cunningham, A. M., Edwards, A. G., Verrier-Jones, K., Bourdeaux, K., Willock, J. and Barnes, R. A. 2005. Evaluation of a service development to increase detection of urinary tract infections in children. Journal of Evaluation in Clinical Practice 11(1), pp. 73-76. (10.1111/j.1365-2753.2004.00507.x)

2004

• White, P. L., Williams, D. W., Kuriyama, T., Samad, S. A., Lewis, M. A. O. and Barnes, R. A. 2004. Detection of Candida in concentrated oral rinse cultures by real-time PCR. Journal of clinical microbiology 42(5), pp. 2101-2107. (10.1128/JCM.42.5.2101-2107.2004)
• Shetty, A. and Barnes Ann, R. 2004. New antifungal agents. British Journal of Hospital Medicine 65(2), pp. 76-79.
• Tan, T. Y. and Barnes, R. A. 2004. Management of infection with naturally amphotericin B resistant fungi. In: Gillespie, S. H. ed. Management of Multiple Drug-Resistant Infections. Infectious Disease Totowa, N.J.: Humana Press, pp. 297-318.
• Barnes, R. A. 2004. Combination chemotherapy and aggressive approaches to the management of systemic fungal infection: the evidentiary basis of current strategies and regimens. In: Prentice, A., Rogers, T. and Miles, A. eds. Key Advances in the Effective Management of Systemic Fungal Infection. UK Key Advances in Medical Practice London: Aesculapius Medical Press, pp. 117-125.
• Shetty, A. and Barnes, R. A. 2004. New developments in antifungal strategy. Expert Review of Anti-infective Therapy 2(2), pp. 269-277. (10.1586/14787210.2.2.269)

2003

• McCracken, D., Barnes, R. A., Poynton, C. H., White, P. L., Isik, N. and Cook, D. 2003. Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia. Journal of Infection 47(4), pp. 344-347. (10.1016/S0163-4453(03)00084-7)
• Denning, D. W., Kibbler, C. C. and Barnes, R. A. 2003. Standards of care for invasive fungal infections - Authors' reply [Letter]. The Lancet Infectious Diseases 3(7), pp. 402-403. (10.1016/S1473-3099(03)00698-4)
• Kibbler, C. C. et al. 2003. Management and outcome of bloodstream infections due to Candida species in England and Wales. Journal of Hospital Infection 54(1), pp. 18-24. (10.1016/S0195-6701(03)00085-9)
• Denning, D. W., Kibbler, C. C. and Barnes, R. A. 2003. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. The Lancet Infectious Diseases 3(4), pp. 230-240. (10.1016/S1473-3099(03)00580-2)
• Shetty, A. and Barnes, R. A. 2003. Community-acquired MRSA infection in a child. Journal of Hospital Infection 53(4), pp. 315. (10.1053/jhin.2002.1379)
• White, P. L., Shetty, A. and Barnes, R. A. 2003. Detection of seven Candida species using the Light-Cycler system. Journal of Medical Microbiology 52(3), pp. 229-238. (10.1099/jmm.0.05049-0)
• Isik, N., White, P. L., Barnes, R. A., Poynton, C. H. and Mills, K. I. 2003. A Simple PCR/RFLP Analysis Can Differentiate Between Candida albicans, Aspergillus niger, and Aspergillus fumigatus. Molecular Biotechnology 24(3), pp. 229-231. (10.1385/MB:24:3:229)

2002

• Davies, J. M., Barnes, R. A. and Milligan, D. 2002. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clinical Medicine 2(5), pp. 440-443.
• Barnes, R. A. 2002. Risk factors for candida infections in the intensive care unit: European perspective. In: Barnes, R. A. and Warnock, D. W. eds. Fungal Infections in the Intensive Care Unit. Perspectives in Critical Care Infectious Diseases Vol. 6. Dordrecht: Kluwer Academic, pp. 45-53., (10.1007/978-1-4615-0977-6_4)

2001

• Barnes, R. A., Cookson, B., Corden, S. and Tan, T. Y. 2001. Rapid Identification of Methicillin-Resistant Staphylococcus aureus from Positive Blood Cultures by Real-Time Fluorescence PCR. Journal of Clinical Microbiology 39(12), pp. 4529-4531. (10.1128/JCM.39.12.4529-4531.2001)
• Barnes, R. A. and Stallard, N. 2001. Severe infections after bone marrow transplantation. Current Opinion in Critical Care 5(7), pp. 362-366.
• Sobanski, M., Barnes, R. A. and Coakley, W. T. 2001. Detection of meningococcal antigen by latex agglutination in methods. In: Pollard, A. J. and Maiden, M. C. eds. Meningococcal Disease: Methods and Protocols. Methods in Molecular Medicine Vol. 67. London: Humana Press, pp. 41-59., (10.1385/1-59259-149-3:41)
• Barnes, R. A. 2001. Environmental factors in the determinant of risk. In: Prentice, A., Rogers, T. and Miles, A. eds. The Effective Prevention and Management of Systemic Fungal Infection in Haematological Malignancy. UK Key Advances in Clinical Practice London: Aesculapius Medical Press, pp. 23-39.
• Milligan, D. et al. 2001. An internet-based multinational study of patients receiving Amphotericin B products [Abstract]. Clinical Infectious Diseases 33(7), pp. 1225. (10.1086/520257)

2000

• Barnes, R. A. 2000. Approaches to antifungal therapy in the intensive care unit. Current Opinion in Infectious Diseases 13(6), pp. 609-614.
• Sobanski, M. et al. 2000. Measurement of serum antigen concentration by ultrasound-enhanced immunoassay and correlation with clinical outcome in meningococcal disease. European Journal of Clinical Microbiology and Infectious Diseases 19(4), pp. 260-266. (10.1007/s100960050473)
• Flanagan, P. G., Findlay, G. P., Magee, J. T., Ionescu, A., Barnes, R. A. and Smithies, M. N. 2000. The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages. Intensive Care Medicine 26(1), pp. 20-30. (10.1007/s001340050007)

1999

• Flanagan, P. G. and Barnes, R. A. 1999. Fungal infections in ICU - a reply [Letter]. Journal of Hospital Infection 41(4), pp. 339-340. (10.1053/jhin.1998.0513)
• Dyson, C., Barnes, R. A. and Harrison, G. A. J. 1999. Infective endocarditis: an epidemiological review of 128 episodes. Journal of Infection 38(2), pp. 87-93. (10.1016/S0163-4453(99)90074-9)
• Gray, S. J. et al. 1999. Ultrasound-enhanced latex immunoagglutination and PCR as complementary methods for non-culture-based confirmation of meningococcal disease. Journal of Clinical Microbiology 37(6), pp. 1797-1801.
• Verrier-Jones, K., Lee, M. L. and Barnes, R. A. 1999. Urinary tract infections are overlooked in children under 2 years in primary care [Abstract]. Kidney International 55(5), pp. 2110. (10.1046/j.1523-1755.1999.00404.x)
• Poynton, C. H., Mickelgard, U., Barnes, R. A. and Jackson, S. 1999. Cytokines and the treatment of deep seated fungal infection - Where is the evidence? [Abstract]. British Journal of Haematology 105(S1), pp. 62.
• Sobanski, M., Gray, S. J., Cafferkey, M., Ellis, R. W., Barnes, R. A. and Coakley, W. T. 1999. Meningitis antigen detection: interpretation of agglutination by ultrasound-enhanced latex immunoassay. British Journal of Biomedical Science 56(4), pp. 239-246.

1998

• Barnes, R. A. 1998. Fungal infections - diagnosis and treatment. In: Barrett, A. J. and Treleaven, J. eds. The clinical practice of stem cell transplantation. Oxford: Isis Medical Media Ltd, pp. 723-740.
• Barnes, R. A. 1998. Other infections. In: Barrett, A. J. and Treleaven, J. eds. The clinical practice of stem cell transplantation. Oxford: Isis medical Media Ltd, pp. 741-742.
• Flanagan, P. G. and Barnes, R. A. 1998. Fungal infection in the intensive care unit. Journal of Hospital Infection 38(3), pp. 163-177. (10.1016/S0195-6701(98)90271-7)
• Poynton, C. H., Barnes, R. A. and Rees, J. 1998. Interferon γ and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia. Clinical Infectious Diseases 26(1), pp. 239-240. (10.1086/517077)
• Barnes, R. A., Jenkins, P. and Coakley, W. T. 1998. Preliminary clinical evaluation of meningococcal disease and bacterial meningitis by ultrasonic enhancement. Archives of Disease in Childhood 78(1), pp. 58-60. (10.1136/adc.78.1.58)
• Mickelgard, U., Jackson, S. K., Barnes, R. A., Rees, J. and Poynton, C. 1998. T cell cytokine profiles and deep seated fungal infection in patients with acute leukaemias [Abstract]. British Journal of Haematology 101(S1), pp. 61.

1997

• Prentice, A. G. et al. 1997. Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy 40(6), pp. 779-788. (10.1093/jac/40.6.779)
• Flanagan, P. G. and Barnes, R. A. 1997. Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection. Journal of Infection 35(3), pp. 295-297. (10.1016/S0163-4453(97)93270-9)

1996

• Barnes, R. A. et al. 1996. Fungal infections: a survey of laboratory services for diagnosis and treatment. Communicable Disease Report CDR Review 6(5), pp. R69-R75.
• Baddeley, P. G. et al. 1996. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. British Medical Journal (BMJ) 312(7028), pp. 430-434. (10.1136/bmj.312.7028.430)

1995

• Grundy, M. A., Barnes, R. A. and Coakley, W. T. 1995. Highly sensitive detection of fungal antigens by ultrasound-enhanced latex agglutination. Journal of Medical and Veterinary Mycology 33(3), pp. 201-203. (10.1080/02681219580000411)

1994

• Barnes, R. A. 1994. Problems after BMT: Brain problems. In: Wiemik, P. and Treleaven, J. eds. A colour atlas and text of bone marrow transplantation. London: Wolfe Publishing Ltd, pp. 181-185.

1993

• Jackson, S. K., Parton, J., Barnes, R. A., Poynton, C. H. and Fegan, C. D. 1993. Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation. European Journal of Clinical Investigation 23(9), pp. 540-545. (10.1111/j.1365-2362.1993.tb00963.x)

1992

• Poynton, C. H., Jackson, S., Fegan, C. D., Barnes, R. A. and Whittaker, J. A. 1992. Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplantation -Basingstoke then London- 9(6), pp. 451-457.
• Barnes, R. A. 1992. Infections following bone marrow transplantation. In: Trevleaven, J. and Barrett, J. eds. Bone Marrow transplantation in practice. Edinburgh: Churchill Livingstone, pp. 281-288.

1991

• Hovenden, J. L., Nicklason, F. and Barnes, R. A. 1991. Invasive pulmonary aspergillosis in non-immunocompromised patients. British Medical Journal (BMJ) 302(6776), pp. 583-584. (10.1136/bmj.302.6776.583)

1990

• Rogers, T. R., Haynes, K. A. and Barnes, R. A. 1990. Value of antigen detection in predicting invasive pulmonary aspergillosis. The Lancet 336(8725), pp. 1210-1213. (10.1016/0140-6736(90)92831-2)

1989

• Barnes, R. A. and Rogers, T. R. 1989. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. Journal of Hospital Infection 14(2), pp. 89-94. (10.1016/0195-6701(89)90110-2)

1988

• Barnes, R. A. and Rogers, T. R. 1988. Response rates to a staged antibiotic regimen in febrile neutropenic patients. Journal of Antimicrobial Chemotherapy 22(5), pp. 759-763. (10.1093/jac/22.5.759)
• Barnes, R. A. 1988. Vaccines, hopes and realities. Journal of the Royal Society of Medicine 81(4), pp. 239-241.
• Rogers, T. R. and Barnes, R. A. 1988. Prevention of airborne fungal infection in immunocompromised patients. Journal of Hospital Infection 11(Supp A), pp. 15-20. (10.1016/0195-6701(88)90160-0)

1987

• Barnes, R. A. and Rogers, T. R. 1987. An evaluation of empirical antibiotic therapy in febrile neutropenic patients. British Journal of Haematology 66(1), pp. 137-140.

1986

• Shaw, P. J., Hugh-Jones, K., Hobbs, J. R., Downie, C. J. and Barnes, R. A. 1986. Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. Bone Marrow Transplantation -Basingstoke then London- 1(2), pp. 193-200.

1984

• Bradley, J., Walt, R., Morris, G. K., Barnes, R. A. and Hamilton, D. V. 1984. Points: Paracetamol overdose as a cause of non-A non-B hepatitis. British Medical Journal (BMJ) 288(6414), pp. 407. (10.1136/bmj.288.6414.407)